Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

21 Feb 2007 09:39

MicroEmissive Displays Group PLC21 February 2007 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached MICROEMISSIVE DISPLAYS GROUP PLC 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights (X) An acquisition or disposal of financial instruments which may result in ( ) the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights ( ) Other (specify): ( ) 3. Full name of person(s) subject to the notification obligation: AXA S.A. 25 Avenue Matignon, 75008 Paris and its group companies 4. Full name of shareholder(s) (if different from 3.) 5. Date of the transaction (and date on which the threshold is crossed or reached if different): 19/02/07 6. Date on which issuer notified: 20/02/07 7. Threshold(s) that is/are crossed or reached: 11% 8. Notified details: A. Voting rights attached to shares Class/type of shares (if possible using the ISIN code) Ordinary (GB00B0346S80) Situation previous to the Resulting situation after the triggering transactiontriggering transactionNumber of Number of Number of Number of voting rights % of votingShares Voting shares rights Rights Direct Direct Indirect Direct Indirect 4,800,000 4,800,000 2,300,000 2,300,000 2,450,000 5.27% 5.62% B. Financial Instruments Resulting situation after the triggering transactionType of Expiration Exercise/ Number of voting rights that may % offinancial date Conversion be acquired if the instrument is votinginstrument Period/Date exercised/converted rights Total (A+B)Number of voting rights % of voting rights 4,750,000 10.89% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: AXA Framlington SEI UK Equity (non-beneficial) 700,000 (1.60%) AXA Framlington Throgmorton Trust (beneficial) 2,300,000 (5.27%) AXA Framlington UK Smaller Cos (non-beneficial) 1,750,000 (4.01%) Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14: Contact name: Terry Marsh 15. Contact telephone number: 020 7003 2637 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.